Anxin Wang
-
- Cardiovascular Health and Disease Prevention 41
- Blood Pressure and Hypertension Studies 18
- Cardiovascular Health and Risk Factors 13
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 35
- Nephrology top 2%
- Epidemiology top 5%
- Acute Ischemic Stroke Management 25
- Liver Disease Diagnosis and Treatment 14
-
- Cerebrovascular and Carotid Artery Diseases 37
-
- Lipoproteins and Cardiovascular Health 15
- Co-authors
- Shouling WuShuohua ChenXingquan ZhaoYanxia LuoYong ZhouXiuhua GuoYingting ZuoYongjun Wang
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Anxin Wang
157 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 133
- Cardiology and Cardiovascular Medicine 1.3k
- Endocrinology, Diabetes and Metabolism 643
- Nephrology 215
- Health, Toxicology and Mutagenesis 383
- Epidemiology 739
Countries citing papers authored by Anxin Wang
This map shows the geographic impact of Anxin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anxin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anxin Wang more than expected).
Fields of papers citing papers by Anxin Wang
This network shows the impact of papers produced by Anxin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anxin Wang. The network helps show where Anxin Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anxin Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 14 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 11 | |
| 9 | 2023 | 4 | |
| 10 | 2022 | 16 | |
| 11 | 2022 | 5 | |
| 12 | 2021 | 33 | |
| 13 | 2021 | 1 | |
| 14 | 2021 | 9 | |
| 15 | 2018 | 7 | |
| 16 | 2016 | 21 | |
| 17 | 2016 | 11 | |
| 18 | 2015 | 1 | |
| 19 | 2014 | 2 | |
| 20 | 2013 | 25 |
About Anxin Wang
Anxin Wang is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Nephrology, having authored 169 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cardiovascular Health and Disease Prevention (41 papers), Cerebrovascular and Carotid Artery Diseases (37 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (35 papers), Acute Ischemic Stroke Management (25 papers), Blood Pressure and Hypertension Studies (18 papers), Lipoproteins and Cardiovascular Health (15 papers), Liver Disease Diagnosis and Treatment (14 papers) and Cardiovascular Health and Risk Factors (13 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.3k citations), Endocrinology, Diabetes and Metabolism (643 citations) and Nephrology (215 citations). Anxin Wang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Shouling Wu, Shuohua Chen, Xingquan Zhao, Yanxia Luo, Yong Zhou, Xiuhua Guo, Yingting Zuo, Yongjun Wang, Xue Tian and Jian Wu.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.